Sanofi begins construction of Singapore vaccine facility
Sanofi has broken ground on its state-of-the-art vaccine facility in Singapore, targeted for completion at the end of 2025.
Stay updated with breaking news from Thomas Triomphe. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sanofi has broken ground on its state-of-the-art vaccine facility in Singapore, targeted for completion at the end of 2025.
Pharma giant Sanofi breaks ground on $638m vaccine facility in S'pore Asia News Network (ANN) is the leading regional alliance of news titles striving to bring the region closer, through an active sharing of editorial content on happenings in the region.
Targeted for completion at the end of 2025, it will churn out vaccines to be used in Asia. . Read more at straitstimes.com.
Sanofi to invest $973 million over five years across two global sites to bring advanced digital and modular vaccine production capabilities to the Asia region
Sanofi’s new DE&I Board, and accompanying Employee Resource Group (ERG) framework, will support the delivery of the company’s DE&I strategy.